WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'7001 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 6'3501 Child (under 5 years) mortality rate: 802

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 1'268  1'250  1'231  1'212  1'193  1'064  863  603 
Births 37  37  37  37  37  34  37  29 
Surviving infants 35  35  35  34  34  31  34  26 
Pop. less than 5 years 171  170  169  167  164  157  166  119 
Pop. less than 15 years 476  473  469  467  463  474  415  294 
Female 15-49 years 329  324  318  313  307  259  207  138 

Number of reported case

(Click for retrospective incidence data for Swaziland)
Diphtheria
Japanese encephalitis
Measles 313  10  1'465 
Mumps 6'773  7'602 
Pertussis 20 
Polio* 192 
Rubella 110  23  20  93  115 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Swaziland)
Vaccine year result method % card seen                                                
BCG 2011  91  EPI   85  99  99  68  98  98  90  96 
DTP1 2011  89  EPI   85  99  99  97  98  95  99* 
DTP3 2011  88  EPI   85  98  98  95  91  89  98  89 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  88  EPI   85  98  98  95  91  89 
Hib3 2011  88  EPI   85  98  98  95  91  89 
JapEnc         
MCV1          97  97  88  98  94  80  85 
MCV2          89  89  52  74  96 
PCV1          90 
PCV3          89 
Pol3 2011  88  EPI   85  98  98  92  85  89  97  89 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  61  EPI   85  72  72  53  79  90  94  76 
PAB         
VAD1          92  92  41  23  99* 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Swaziland)
BCG 99  99  99  98  98  88  96 
DTP1 99  99  97  98  95  94  96 
DTP3 98  98  95  91  89  84  89 
HepB3 98  98  95  91  89  83 
HepB_BD
Hib3 98  98  95  91  89 
MCV1 86  85  77  87  94  92  85 
MCV2 89  89  52  92  99 
PAB 88  86  86  86  86  80  63 
PCV3 67 
Pol3 98  98  92  85  89  87  89 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 25
From 50 to 79% 25
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB 1st contact; +1, +2 months; Yes Health workers
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 18 months; 5 years; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1,+1 years; 15-49 years
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 75  25  25  100  50 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 97  97  50  48  90  90 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.